Table 1 Summary of RNA-sequencing and mapping results
Time point | Condition | Number of input reads | Number of uniquely mapped reads | Uniquely mapped reads % |
|---|---|---|---|---|
T1 | Baseline Control | 22,035,322 (18,767,889-26,400,889) | 17,130,560 (14,538,711-20,630,864) | 77.69 (77.47–78.14) |
T4 | Control | 22,496,254 (19,113,114-25,212,429) | 17,574,219 (14,954,558-19,584,476) | 78.14 (77.68–78.5) |
T9 | Control | 19,503,128 (18,889,722-20,042,058) | 15,364,519 (14,898,108-15,598,512) | 78.79 (77.82–79.68) |
T21 | Control | 22,109,409 (19,805,446-26,471,942) | 17,150,393 (15,345,112-20,413,654) | 77.62 (77.11–78.26) |
T39 | Control | 20,954,099 (19,548,183-22,982,591) | 16,150,647 (15,021,861-17,772,272) | 77.06 (76.85–77.33) |
T4 | Infected | 20,294,334 (17,827,443-22,137,544) | 16,042,961 (14,297,556-17,475,634) | 79.11 (78.19–80.20) |
T9 | Infected | 20,571,206 (17,652,233-22,094,245) | 16,243,524 (13,782,277-17,487,010) | 78.91 (78.08–79.61) |
T21 | Infected | 18,552,412 (18,380,964-18,769,955) | 10,972,473 (9,567,906-12,175,200) | 59.18 (50.97–65.79) |
T39 | Infected with symptoms | 18,284,058 (17,804,501-18,763,615) | 6,652,156 (6,600,580-6,703,731) | 36.42 (35.18–37.65) |
T39 | Infected without symptoms | 20,227,789 (19,812,720-20,642,858) | 15,663,373 (15,240,145-16,086,601) | 77.43 (76.92–77.93) |